LUREX BIO, INC

Amendment
CIK: 0002108090·Biotechnology·DELAWARE·Filed: Aug 31, 2026
Total Offering

Indefinite

Amount Sold

$150,000

Investors

3

First Sale

Jan 22, 2026

Offering Details

Type
Equity, Debt
Exemptions
Rule 506(c)
Entity Type
Corporation
Year Incorporated
2025
Non-Accredited Investors
No

Related Persons

NameRole
George Sens
Mark Shumate
Horace Lanier, III
James Clark

Company

LUREX BIO, INC

501 EAST LAS OLAS BLVD., SUITE 300

FORT LAUDERDALE, FL, 33301

8555873924

SEC Filing

0002108090-26-000004

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free